Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain

NCT02820519 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Intolerable high amount of adverse events

Conditions

Neuropathic Pain

Interventions

DRUG: Loxapine

Sponsor

University of Witten/Herdecke